Reviews Increlex


No reviews yet.

Increlex Drug Description
INCRELEX®
(mecasermin [rDNA origin]) Injection
DRUG DESCRIPTION



What are the possible side effects of mecasermin (Increlex)?

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your child's face, lips, tongue, or throat.
Call your doctor at once if your child has a serious side effect such as:

blurred vision, headache or pain behind the eyes, sometimes with vomiting;
pain in the hip or knee, walking with a limp;
seizure (convulsions); or
swollen tonsils - snoring, breathing problems during sleep, ear...
Read All Potential Side Effects for Increlex »




INCRELEX® (mecasermin [rDNA origin] injection) is an aqueous solution for
injection containing human insulin-like growth factor-1 (rhIGF-1) produced by
recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain
with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
The amino acid sequence of the product is identical to that of endogenous human
IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been
modified by the addition of the gene for human IGF-1.
Primary Amino Acid Sequence of rhIGF-1







INCRELEX® is a purified preparation. Biological potency is determined using
a bioassay.
INCRELEX® is a sterile, aqueous, clear and colorless solution intended
for subcutaneous injection. Each multi-dose vial of INCRELEX® contains 10
mg/mL mecasermin, 9 mg/mL benzyl alcohol, 5.84 mg/mL sodium chloride, 2 mg/mL
polysorbate 20, and 0.05M acetate at a pH of approximately 5.4.Last reviewed on RxList: 2/20/2009




Increlex Drug Description
INCRELEX®
(mecasermin [rDNA origin]) Injection
DRUG DESCRIPTION



What are the possible side effects of mecasermin (Increlex)?

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your child's face, lips, tongue, or throat.
Call your doctor at once if your child has a serious side effect such as:

blurred vision, headache or pain behind the eyes, sometimes with vomiting;
pain in the hip or knee, walking with a limp;
seizure (convulsions); or
swollen tonsils - snoring, breathing problems during sleep, ear...
Read All Potential Side Effects for Increlex »




INCRELEX® (mecasermin [rDNA origin] injection) is an aqueous solution for
injection containing human insulin-like growth factor-1 (rhIGF-1) produced by
recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain
with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
The amino acid sequence of the product is identical to that of endogenous human
IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been
modified by the addition of the gene for human IGF-1.
Primary Amino Acid Sequence of rhIGF-1







INCRELEX® is a purified preparation. Biological potency is determined using
a bioassay.
INCRELEX® is a sterile, aqueous, clear and colorless solution intended
for subcutaneous injection. Each multi-dose vial of INCRELEX® contains 10
mg/mL mecasermin, 9 mg/mL benzyl alcohol, 5.84 mg/mL sodium chloride, 2 mg/mL
polysorbate 20, and 0.05M acetate at a pH of approximately 5.4.Last reviewed on RxList: 2/20/2009




Increlex Drug Description
INCRELEX®
(mecasermin [rDNA origin]) Injection
DRUG DESCRIPTION



What are the possible side effects of mecasermin (Increlex)?

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your child's face, lips, tongue, or throat.
Call your doctor at once if your child has a serious side effect such as:

blurred vision, headache or pain behind the eyes, sometimes with vomiting;
pain in the hip or knee, walking with a limp;
seizure (convulsions); or
swollen tonsils - snoring, breathing problems during sleep, ear...
Read All Potential Side Effects for Increlex »




INCRELEX® (mecasermin [rDNA origin] injection) is an aqueous solution for
injection containing human insulin-like growth factor-1 (rhIGF-1) produced by
recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain
with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
The amino acid sequence of the product is identical to that of endogenous human
IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been
modified by the addition of the gene for human IGF-1.
Primary Amino Acid Sequence of rhIGF-1







INCRELEX® is a purified preparation. Biological potency is determined using
a bioassay.
INCRELEX® is a sterile, aqueous, clear and colorless solution intended
for subcutaneous injection. Each multi-dose vial of INCRELEX® contains 10
mg/mL mecasermin, 9 mg/mL benzyl alcohol, 5.84 mg/mL sodium chloride, 2 mg/mL
polysorbate 20, and 0.05M acetate at a pH of approximately 5.4.Last reviewed on RxList: 2/20/2009




Increlex Drug Description
INCRELEX®
(mecasermin [rDNA origin]) Injection
DRUG DESCRIPTION



What are the possible side effects of mecasermin (Increlex)?

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your child's face, lips, tongue, or throat.
Call your doctor at once if your child has a serious side effect such as:

blurred vision, headache or pain behind the eyes, sometimes with vomiting;
pain in the hip or knee, walking with a limp;
seizure (convulsions); or
swollen tonsils - snoring, breathing problems during sleep, ear...
Read All Potential Side Effects for Increlex »




INCRELEX® (mecasermin [rDNA origin] injection) is an aqueous solution for
injection containing human insulin-like growth factor-1 (rhIGF-1) produced by
recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain
with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
The amino acid sequence of the product is identical to that of endogenous human
IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been
modified by the addition of the gene for human IGF-1.
Primary Amino Acid Sequence of rhIGF-1







INCRELEX® is a purified preparation. Biological potency is determined using
a bioassay.
INCRELEX® is a sterile, aqueous, clear and colorless solution intended
for subcutaneous injection. Each multi-dose vial of INCRELEX® contains 10
mg/mL mecasermin, 9 mg/mL benzyl alcohol, 5.84 mg/mL sodium chloride, 2 mg/mL
polysorbate 20, and 0.05M acetate at a pH of approximately 5.4.Last reviewed on RxList: 2/20/2009




Increlex Drug Description
INCRELEX®
(mecasermin [rDNA origin]) Injection
DRUG DESCRIPTION



What are the possible side effects of mecasermin (Increlex)?

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your child's face, lips, tongue, or throat.
Call your doctor at once if your child has a serious side effect such as:

blurred vision, headache or pain behind the eyes, sometimes with vomiting;
pain in the hip or knee, walking with a limp;
seizure (convulsions); or
swollen tonsils - snoring, breathing problems during sleep, ear...
Read All Potential Side Effects for Increlex »




INCRELEX® (mecasermin [rDNA origin] injection) is an aqueous solution for
injection containing human insulin-like growth factor-1 (rhIGF-1) produced by
recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain
with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
The amino acid sequence of the product is identical to that of endogenous human
IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been
modified by the addition of the gene for human IGF-1.
Primary Amino Acid Sequence of rhIGF-1







INCRELEX® is a purified preparation. Biological potency is determined using
a bioassay.
INCRELEX® is a sterile, aqueous, clear and colorless solution intended
for subcutaneous injection. Each multi-dose vial of INCRELEX® contains 10
mg/mL mecasermin, 9 mg/mL benzyl alcohol, 5.84 mg/mL sodium chloride, 2 mg/mL
polysorbate 20, and 0.05M acetate at a pH of approximately 5.4.Last reviewed on RxList: 2/20/2009





Other reviews about Increlex on wordpress

2005 Drug Approvals
  by Mike
New molecular entities and new biologicals, 2005a Abatacept for i.v. infusion, (Orencia, Bristol-Myers Squibb), for the second-line treatment of adults with moderately to severely active rheumatoid arthritis. Conivaptan hydrochloride injection […]


Drugs Approved by the FDA (2005)
  by Karthikram
Drugs which got approval from FDA for the year 2005. Happy to see more than a dozen drugs..Hope to see more than 30 this year..New technologies will be […]


Insmed Loses Patent Case to Tercica; Companies Should Merge
  by 247wallst
From BioHealth Investorby Andrew VainoAs I mentioned last week in the Daily Blog, the patent case between Insmed (INSM) and Tercica (TRCA) was decided in Tercica's favor. A […]


Tercica (TRCA): More Small Cap BioTech Madness
  by 247wallst
Tercica (TRCA) is a small biotech which had an operating loss of $86 million last year on revenue of a little over $1 million. The year's numbers have […]


Hope is alive!
  by spatzgear
What a miraculous day!┬á All the tears, all the dreams, all the hope... IRSF announces funding for a┬á clinical trial with a growth-factor based treatment for Rett Syndrome.┬á […]


Initial IGF1 Study Guidelines
  by spatzgear
Hi Everyone, I am sending a message from Dr Tony Horton, IRSF CSO, about this exciting study.┬á We will share more info as the researchers get organized and begin […]


Did you say something?
  by doris123
IRSF has announced the first clinical trial for a drug which might help with the symptoms of Rett Syndrome. The clinical trial is funded with $200,000 presumably from […]


FDA: Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between January - March 2009
  by thassodotcom
October 9, 2009 -┬á The American Food and Drug Administration (FDA) has just published the list below with the names of drug products and potential signals of serious […]


DJ PRESSESPIEGEL/Zinsen, Konjunktur, Kapitalm├Ąrkte...
  by ddpdirect
DJ PRESSESPIEGEL/Zinsen, Konjunktur, Kapitalm├Ąrkte, Branchen DJ PRESSESPIEGEL/Zinsen, Konjunktur, Kapitalm├Ąrkte, Branchen BANKEN - Der von Deutsche-Bank-Chef Josef Ackermann vorgeschlagene Rettungsfonds f├╝r Gro├čbanken r├╝ckt offenbar n├Ąher. Vertreter europ├Ąischer Gro├čbanken signalisierten am Rande […]


Distribution agreement between Ipsen and Invida
  by silico
On April 27 2010 Ipsen and Invida Group signed an agreement for the exclusive distribution and promotion by Invida of IpsenÔÇÖs drugs Diphereline┬« 3.75mg & 11.25mg, Somatuline┬« Autogel┬« […]



Other reviews about Increlex on web:

Learn about Increlex® (mecasermin), the only FDA-approved treatment for severe Primary IGFD, a unique short stature disorder. Increlex: the only FDA-approved treatment used for severe Primary ...


Increlex (mecasermin) is used to treat growth failure in children whose bodies do not make enough IGF-1. Includes Increlex side effects, interactions and indications. Increlex Information from Drugs.com


For many years, natural growth hormone was the only treatment available for children with short stature. In the 1980s, manmade—or "recombinant"—growth hormone was introduced, 4 ... About Increlex : Increlex


Accurate, FDA approved Increlex information for healthcare professionals and patients - brought to you by Drugs.com. Increlex Official FDA information, side effects and uses.


Learn about the prescription medication Increlex (Mecasermin [rDNA origin] Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Increlex (Mecasermin [rDNA origin] Injection) Drug Information ...


What is Increlex (Mecasermin)? Mecasermin is a man-made form of insulin-like growth factor-1 (IGF-1), a substance that is normally produced in the body. Increlex - Drugs & Treatments - Revolution Health


Increlex and Mecasermin Information. News and Information on Increlex, Attorneys and Lawyers at LegalView.info Increlex and Mecasermin - Attorney, Lawsuit, Law Suit, Case, Claim ...


Organized by therapeutic area, this comprehensive listing of FDA-Approved Drugs by the Food and Drug Administration features facts on clinical trial results, side effects and other ... Newly Approved Drug Therapies (884) Increlex (mecasermin), Tercica,


Drug information and side-effects for Increlex (mecasermin) Increlex (mecasermin) - Drug information from MediLexicon


Increlex Side Effects: aggression, anaphylactic reaction, back pain. Increlex Reports: patient, 13 years of age, weighting 55.. Increlex Reviews: I am 14 and take 15 CC's of ... Increlex Side Effects





Featured Reviews

Reviews Namenda XR

Namenda XR Drug Description NAMENDA XR (memantine hydrochloride) Extended Release Capsules DRUG DESCRIPTION NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane...
Read More  |  Review This
Reviews Cardene SR

Cardene SR Drug Description CARDENE® SR (nicardipine hydrochloride) Sustained Release Capsules DRUG DESCRIPTION What are the possible side effects of nicardipine (Cardene, Cardene SR)? If you experience any of the following...
Read More  |  Review This
Reviews Paroxetine Mesylate

Pexeva Drug Description PEXEVA® (paroxetine mesylate) Tablets Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents,...
Read More  |  Review This
Reviews Foradil Aerolizer

Foradil Aerolizer Drug Description FORADIL® AEROLIZER® (formoterol fumarate) Inhalation Powder WARNING ASTHMA RELATED DEATH Long-acting beta2-adrenergic agonists (LABA), such as formoterol the active ingredient in FORADIL...
Read More  |  Review This
Reviews Lansoprazole for Injection

Prevacid I.V. Drug Description PREVACID® I.V. (lansoprazole) for Injection 30 mg/vial DRUG DESCRIPTION The active ingredient in PREVACID I.V. (lansoprazole) for Injection is a substituted benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoro...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....